0001818382-22-000201.txt : 20221212 0001818382-22-000201.hdr.sgml : 20221212 20221212161515 ACCESSION NUMBER: 0001818382-22-000201 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221208 FILED AS OF DATE: 20221212 DATE AS OF CHANGE: 20221212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scheessele William John CENTRAL INDEX KEY: 0001879378 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39532 FILM NUMBER: 221457270 MAIL ADDRESS: STREET 1: 620 WADE AVENUE STREET 2: UNIT 501 CITY: RALEIGH STATE: NC ZIP: 27605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Humacyte, Inc. CENTRAL INDEX KEY: 0001818382 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851763759 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-313-9633 MAIL ADDRESS: STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: Alpha Healthcare Acquisition Corp. DATE OF NAME CHANGE: 20200716 4 1 wf-form4_167087968780298.xml FORM 4 X0306 4 2022-12-08 0 0001818382 Humacyte, Inc. HUMA 0001879378 Scheessele William John 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 0 1 0 0 Chief Commercial Officer Stock Options (right to buy) 3.07 2022-12-08 4 A 0 136000 0 A 2032-12-08 Common Stock 136000.0 136000 D The first 25% of the option becomes exercisable on December 8, 2023, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2026. /s/ William John Scheessele by Dale A. Sander as Attorney-in-Fact 2022-12-12